K.-C. Cheng

884 total citations
14 papers, 582 citations indexed

About

K.-C. Cheng is a scholar working on Oncology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, K.-C. Cheng has authored 14 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Computational Theory and Mathematics and 5 papers in Pharmacology. Recurrent topics in K.-C. Cheng's work include Drug Transport and Resistance Mechanisms (6 papers), Computational Drug Discovery Methods (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). K.-C. Cheng is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Computational Drug Discovery Methods (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). K.-C. Cheng collaborates with scholars based in United States, Canada and Hong Kong. K.-C. Cheng's co-authors include Eric Novik, Piyun Chao, Timothy J. Maguire, Martin L. Yarmush, Xiaoming Cui, Ronald E. White, Yau Yi Lau, Annette S. Uss, Cheng Li and Tongtong Liu and has published in prestigious journals such as Biochemical Pharmacology, The Journals of Gerontology Series A and Drug Metabolism and Disposition.

In The Last Decade

K.-C. Cheng

14 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K.-C. Cheng United States	9	307	148	140	138	117	14	582
J. E. Dinger Germany	10	181 0.6×	84 0.6×	87 0.6×	116 0.8×	49 0.4×	12	432
Tracy Walker United Kingdom	9	78 0.3×	55 0.4×	59 0.4×	171 1.2×	55 0.5×	11	397
Henrik Palmgren Sweden	6	69 0.2×	74 0.5×	93 0.7×	159 1.2×	23 0.2×	9	336
Kristin Samuelsson Sweden	13	51 0.2×	68 0.5×	21 0.1×	96 0.7×	37 0.3×	28	352
Elijah J. Weber United States	8	349 1.1×	71 0.5×	16 0.1×	250 1.8×	51 0.4×	12	610
Magnus Ölander Sweden	8	34 0.1×	25 0.2×	38 0.3×	92 0.7×	70 0.6×	15	287
Hossein Hamzeiy Iran	12	69 0.2×	82 0.6×	15 0.1×	178 1.3×	31 0.3×	21	374
Takashi Uesugi Japan	11	23 0.1×	65 0.4×	9 0.1×	119 0.9×	111 0.9×	45	449
Zhihui Yan China	15	69 0.2×	12 0.1×	22 0.2×	323 2.3×	21 0.2×	46	626
Raf Van Campenhout Belgium	11	21 0.1×	31 0.2×	27 0.2×	167 1.2×	17 0.1×	22	286

Countries citing papers authored by K.-C. Cheng

Since Specialization

Citations

This map shows the geographic impact of K.-C. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.-C. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.-C. Cheng more than expected).

Fields of papers citing papers by K.-C. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.-C. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.-C. Cheng. The network helps show where K.-C. Cheng may publish in the future.

Co-authorship network of co-authors of K.-C. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of K.-C. Cheng. A scholar is included among the top collaborators of K.-C. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.-C. Cheng. K.-C. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Cheng, K.-C., et al.. (2023). A cell culture system to model pharmacokinetics using adjustable-volume perfused mixing chambers. Toxicology in Vitro. 91. 105623–105623. 2 indexed citations

2.

Yamaguchi, Takeshi, K.-C. Cheng, Sandra McKay, & Brian E. Maki. (2014). Footwear width and balance-recovery reactions: A new approach to improving lateral stability in older adults. Gerontechnology. 13(3). 359–367. 6 indexed citations

3.

Cheng, K.-C., Sandra McKay, Emily C. King, & Brian E. Maki. (2012). Does Aging Impair the Capacity to Use Stored Visuospatial Information or Online Visual Control to Guide Reach-to-Grasp Reactions Evoked by Unpredictable Balance Perturbation?. The Journals of Gerontology Series A. 67(11). 1238–1245. 23 indexed citations

4.

Maguire, Timothy J., Eric Novik, Piyun Chao, et al.. (2009). Design and Application of Microfluidic Systems for In Vitro Pharmacokinetic Evaluation of Drug Candidates. Current Drug Metabolism. 10(10). 1192–1199. 35 indexed citations

5.

Chao, Piyun, Timothy J. Maguire, Eric Novik, K.-C. Cheng, & Martin L. Yarmush. (2009). Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human. Biochemical Pharmacology. 78(6). 625–632. 132 indexed citations

6.

Novik, Eric, Timothy J. Maguire, Piyun Chao, K.-C. Cheng, & Martin L. Yarmush. (2009). A microfluidic hepatic coculture platform for cell-based drug metabolism studies. Biochemical Pharmacology. 79(7). 1036–1044. 168 indexed citations

7.

Hsieh, Yunsheng, K.-C. Cheng, Yuguang Wang, et al.. (2009). The Role of Exploratory Drug Metabolism and Pharmacokinetics in New Drug Research: Case Study-Selection of a Thrombin Receptor Antagonist for Development. Current Pharmaceutical Design. 15(19). 2262–2269. 2 indexed citations

8.

Chao, Piyun, et al.. (2009). Prediction of Human Hepatic Clearance Using an In Vitro Plated Hepatocyte Clearance Model. Drug Metabolism Letters. 3(4). 296–307. 15 indexed citations

9.

Li, Cheng, Tongtong Liu, Xiaoming Cui, Annette S. Uss, & K.-C. Cheng. (2007). Development of In Vitro Pharmacokinetic Screens Using Caco-2, Human Hepatocyte, and Caco-2/Human Hepatocyte Hybrid Systems for the Prediction of Oral Bioavailability in Humans. SLAS DISCOVERY. 12(8). 1084–1091. 49 indexed citations

10.

Cheng, K.-C., Walter A. Korfmacher, Ronald E. White, & F. George Njoroge. (2007). Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034.. PubMed. 1. 1–9. 8 indexed citations

11.

Cheng, K.-C., Walter A. Korfmacher, Ronald E. White, & F. George Njoroge. (2007). Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034. 1. 6 indexed citations

12.

Cui, Xiaoming, Ann Thomas, Yi Han, et al.. (2005). Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: Correlation study with induction in vivo. Journal of Pharmacological and Toxicological Methods. 52(2). 234–243. 20 indexed citations

13.

Cheng, K.-C., et al.. (2005). Development of a high-throughput in vitro assay using a novel Caco-2/rat hepatocyte system for the prediction of oral plasma area under the concentration versus time curve (AUC) in rats. Journal of Pharmacological and Toxicological Methods. 53(3). 215–218. 8 indexed citations

14.

Lau, Yau Yi, et al.. (2002). Development of a Novel in Vitro Model to Predict Hepatic Clearance Using Fresh, Cryopreserved, and Sandwich-Cultured Hepatocytes. Drug Metabolism and Disposition. 30(12). 1446–1454. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact